Abstract
Background
To compare the efficacy of letrozole-stimulated cycles to the more conventional artificial programmed cycles, in endometrial preparation for frozen embryo transfer (FET), in terms of endometrial parameters, reproductive outcomes, other practical parameters like number of visits to the clinic, cost involved, and patient satisfaction.
Methods
This prospective cohort study was conducted at Rao Hospital for a period of 11 months. The study included a total of 152 cycles of frozen embryo transfers. Fifty-five women selected for Group A underwent letrozole FET. Ninety-seven women selected for Group B had an artificial hormone replacement for endometrial preparation, prior to FET. All patients were followed-up with serial ultrasounds and FET done when endometrium reached desired state.
Results
The endometrial thickness was comparable in both the groups, and on 3D endostudy, the flow index was non-significantly higher in the hormone replacement therapy (HRT) group. Other variables like vascularity index (VI), volume, and vascularization flow index (VFI) were similar in the two groups. The clinical pregnancy rate was higher in the letrozole group than the artificial cycle group, though not with significant difference. The live birth rate was higher in the patients on HRT than letrozole. The miscarriage rates were comparable in both groups. The medical comorbidities were significantly higher in the HRT cycles.
Conclusion
Letrozole FET could be a better alternative to the conventional HRT cycles, in selected population of patients, in terms of reproductive outcomes and patient satisfaction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Li D, Khor S, Huang J, et al. Frozen embryo transfer in mildly stimulated cycle with letrozole compared to natural cycle in ovulatory women: a large retrospective study. Front Endocrinol (Lausanne). 2021;22(12): 677689. https://doi.org/10.3389/fendo.2021.677689. (PMID: 34630318; PMCID: PMC8493067).
Munch EM, Burger NZ. Uterine preparation prior to frozen embryo transfer using letrozole: a case series. Fertil Steril [Internet]. 2018; 109(3): e39. https://doi.org/10.1016/j.fertnstert.2018.02.076
Ginström Ernstad E, Wennerholm UB, Khatibi A, et al. Neonatal and maternal outcome after frozen embryo transfer: Increased risks in programmed cycles. Am J Obstet Gynecol. 2019;221(2):126.e1-126.e18. https://doi.org/10.1016/j.ajog.2019.03.010. (Epub 2019 Mar 22 PMID: 30910545).
Atkinson M, Crittenden J, Smith H, et al. Retrospective cohort study on preparation regimens for frozen embryo transfer. Reprod Fertil. 2021;2(4):308–16. https://doi.org/10.1530/RAF-21-0044. (PMID: 35118408; PMCID: PMC8788575).
Elgindy EA, Abdelghany AA, Sibai AbdAlsalam H, et al. The novel incorporation of aromatase inhibitor in hormonal replacement therapy cycles: a randomized controlled trial. Reprod Biomed Online. 2022;44(4):641–9. https://doi.org/10.1016/j.rbmo.2021.10.025. (Epub 2021 Dec 20 PMID: 35288021).
Chen D, Shen X, Fu Y, et al. Pregnancy outcomes following letrozole use in frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. Geburtshilfe Frauenheilkd. 2020;80(8):820–33. https://doi.org/10.1055/a-1202-2059. (Epub 2020 Aug 14 PMID: 32817989; PMCID: PMC7428376).
Zhang J, Liu H, Wang Y, et al. Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome. Fertil Steril. 2019;112(2):371–7. https://doi.org/10.1016/j.fertnstert.2019.04.014. (Epub 2019 May 21 PMID: 31126712).
Litzky JF, Boulet SL, Esfandiari N, et al. Effect of frozen/thawed embryo transfer on birthweight, macrosomia, and low birthweight rates in US singleton infants. Am J Obstet Gynecol. 2018;218(4):433.e1-433.e10. https://doi.org/10.1016/j.ajog.2017.12.223. (Epub 2017 Dec 29 PMID: 29291410; PMCID: PMC5878119).
Hu KL, Zhang D, Li R. Endometrium preparation and perinatal outcomes in women undergoing single-blastocyst transfer in frozen cycles. Fertil Steril. 2021;115(6):1487–94. https://doi.org/10.1016/j.fertnstert.2020.12.016. (Epub 2021 Jan 22 PMID: 33487443).
Samsami A, Ghasmpour L, Davoodi S, et al. Frozen embryo transfer: endometrial preparation by letrozole versus hormone replacement cycle: a randomized clinical trial. Int J Reprod Biomed. 2019;17(12):915–22. https://doi.org/10.18502/ijrm.v17i12.5793. (PMID: 31970313; PMCID: PMC6943798).
Funding
No funding was received to do this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest.
Ethical approval
All subjects gave their informed consent for inclusion in the study. The study was conducted in accordance with the Declaration of Helsinki. Institutional Human Ethics Commitee PSG-IMSR.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Dr. Asha Rao is a director and chief consultant in ART and high-risk pregnancies, principal for the TNMGR post doctoral fellowship program. Dr. Aiswarya is a post doctoral fellow in reproductive medicine. Dr. Padmashri is a sonologist. Dr. Damodar Rao is a senior consultant.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rao, A.R., Aiswarya, R., Padmashri, G. et al. A Non-Inferiority Study on Endometrial Preparation Prior to FET-Letrozole Versus Hormone Replacement Therapy. J Obstet Gynecol India (2024). https://doi.org/10.1007/s13224-023-01923-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13224-023-01923-z